Outcome of Diabetic and Non-Diabetic Patients Undergoing Successful Percutaneous Coronary Intervention of Chronic Total Occlusion

Diabetes mellitus is associated with an increased risk of adverse clinical outcomes afterpercutaneous coronary intervention (PCI). The prognosis of patients with diabetesmellitus and chronic total occlusion (CTO) treated with PCI is poorly investigated.Current study evaluates outcome of successful PCI on CTO in patients with and withoutdiabetes. One hundred and sixty three patients treated with successful PCI on CTObetween January 2009 and March 2011 were prospectively identified from the PCIregistry at the Madani Heart Center, Tabriz, Iran. Patients were followed for 15±3months, were evaluated for the occurrence of major adverse cardiac events (MACE)comprising death, acute myocardial infarction, and need for repeat revascularization. No differences were found in baseline clinical and procedural variables between patientswith (n=34) and without diabetes (n=129), unless for hypertension (p=0.03).Hospitalization period after PCI in diabetics (3.26±0.61 days) and non-diabetics(2.86±0.52 days) was similar. In-hospital MACE occurred in 8 (23.5%) individuals ofdiabetics and 10 (7.8%) individuals of non-diabetics (p=0.02), among themrevascularization was significantly higher in diabetics (20.6% vs. 7%, p=0.04). Follow-upevents in diabetic and non-diabetic groups were 12 (35.3%) and 37 (28.5%), respectively(p was not significant). In patients undergoing successful PCI on CTO, diabetes isassociated with higher in-hospital adverse events; however diabetes does not affect longterm outcomes in these patients.